David A. Siegel Codexis, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Codexis, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 46,000 shares of CDXS stock, worth $126,040. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,000
Previous 99,500
53.77%
Holding current value
$126,040
Previous $267,000
58.05%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding CDXS
# of Institutions
129Shares Held
69MCall Options Held
25.8KPut Options Held
20K-
Opaleye Management Inc. Boston, MA12.6MShares$34.5 Million7.35% of portfolio
-
Casdin Capital, LLC New York, NY7.2MShares$19.7 Million2.46% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$18.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.59MShares$12.6 Million0.0% of portfolio
-
Abrdn PLC4.2MShares$11.5 Million0.02% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $179M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...